Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details) - Schedule of stock options outstanding and exercisable

v3.21.2
Stockholders' Equity (Details) - Schedule of stock options outstanding and exercisable
 6 Months Ended
Jun. 30, 2021
$ / shares
shares
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Stock Options, Weighted Average Exercise Price
Stock Options, Total Outstanding (in Shares) (in Shares) | shares 10,944,413
Stock Options, Number Exercisable (in Shares) (in Shares) | shares 5,687,911
Grant Price From 0.26 to 2.02 [Member]  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Stock Options, Grant Price, Minimum $ 0.26
Stock Options, Weighted Average Exercise Price $ 1.14
Stock Options, Total Outstanding (in Shares) (in Shares) | shares 7,430,746
Stock Options, Number Exercisable (in Shares) (in Shares) | shares 2,585,392
Stock Options, Weighted Average Remaining Contractual Term 7 years 10 months 13 days
Stock Options, Grant Price, Maximum $ 2.02
Grant Price From 2.10 to 4.60 [Member]  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Stock Options, Grant Price, Minimum 2.10
Stock Options, Weighted Average Exercise Price $ 2.46
Stock Options, Total Outstanding (in Shares) (in Shares) | shares 2,920,667
Stock Options, Number Exercisable (in Shares) (in Shares) | shares 2,537,437
Stock Options, Weighted Average Remaining Contractual Term 7 years 2 months 4 days
Stock Options, Grant Price, Maximum $ 4.60
Grant Price From 5.30 to 8.86 [Member]  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Stock Options, Grant Price, Minimum 5.30
Stock Options, Weighted Average Exercise Price $ 6.25
Stock Options, Total Outstanding (in Shares) (in Shares) | shares 593,000
Stock Options, Number Exercisable (in Shares) (in Shares) | shares 565,082
Stock Options, Weighted Average Remaining Contractual Term 6 years 10 months 2 days
Stock Options, Grant Price, Maximum $ 8.86